Department of Diagnostic Pathology and Cytology, Osaka International Cancer Institute, Osaka, Japan.
Department of Pathology, Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, Tokyo, Japan.
J Cutan Pathol. 2022 Sep;49(9):765-771. doi: 10.1111/cup.14246. Epub 2022 May 10.
The status of cutaneous epithelioid angiomatous nodule (CEAN) as a distinct entity remains controversial. This study investigated the relationship between CEAN and epithelioid hemangioma/angiolymphoid hyperplasia with eosinophilia (ALHE).
Data of seven lesions with CEAN features from four cases (Cases 1-4: 61-year-old, 76-year-old, 53-year-old, and 21-year-old men, respectively) were investigated.
Cases 1 and 2 showed multiple lesions in the head and neck region, but Cases 3 and 4 showed solitary lesions on the back and scalp, respectively. Moreover, the histopathologic findings of the lesions of Cases 1 and 2 were consistent with those of conventional epithelioid hemangioma or classic cutaneous ALHE. Diffuse immunoexpression of FOSB was observed in Cases 1 and 2, but FOSB split signals were absent in break-apart fluorescence in situ hybridization (FISH). In contrast, the histopathologic findings of the lesions of Cases 3 and 4 were consistent with those of cellular-type epithelioid hemangiomas. Diffuse immunoreactivity for c-FOS was observed in Cases 3 and 4, and split signals of FOS were present in break-apart FISH in Case 3.
This study showed that the seven tumors with CEAN features could be reclassified under the epithelioid hemangioma/ALHE group, although the small sample size is a limitation.
皮肤上皮样血管性结节(CEAN)作为一种独特实体的地位仍存在争议。本研究探讨了 CEAN 与上皮样血管瘤/血管淋巴样增生伴嗜酸性粒细胞增多症(ALHE)之间的关系。
研究了来自四个病例(病例 1-4:分别为 61 岁、76 岁、53 岁和 21 岁的男性)的七个具有 CEAN 特征的病变的数据。
病例 1 和 2 表现为头颈部多发性病变,而病例 3 和 4 则分别表现为背部和头皮的单一病变。此外,病例 1 和 2 的病变的组织病理学发现与传统上皮样血管瘤或经典皮肤 ALHE 的发现一致。弥漫性 FOSB 免疫表达在病例 1 和 2 中观察到,但分离荧光原位杂交(FISH)中不存在 FOSB 分裂信号。相比之下,病例 3 和 4 的病变的组织病理学发现与细胞型上皮样血管瘤的发现一致。弥漫性 c-FOS 免疫反应在病例 3 和 4 中观察到,在病例 3 中分离 FISH 中存在 FOS 的分裂信号。
本研究表明,具有 CEAN 特征的七个肿瘤可以重新分类到上皮样血管瘤/ALHE 组中,尽管样本量小是一个限制。